$TRVN
TREVENA INC Stock $trvn

$trvn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000155837024004445 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$20.00K	$3.125M	$3.125M
YoY Change	233.33%		-847.61%
Cost Of Revenue	$88.00K	$1.670M	$1.670M
YoY Change	-30.71%	635.68%	-44.67%
Gross Profit	-$68.00K	$1.455M	$1.455M
YoY Change	-43.8%	-740.97%	-142.35%
Gross Profit Margin	-340.0%	46.56%	46.56%
Selling, General & Admin	$5.845M	$20.41M	$20.41M
YoY Change	-4.01%	256.51%	-41.23%
% of Gross Profit		1402.75%	1402.75%
Research & Development	$3.965M	$16.33M	$16.33M
YoY Change	1.43%	381.09%	-10.31%
% of Gross Profit		1122.54%	1122.54%
Depreciation & Amortization	$88.00K	$84.00K	$300.0K
YoY Change	7.32%	2.44%	-25.0%
% of Gross Profit		5.77%	20.62%
Operating Expenses	$3.965M	$36.74M	$16.33M
YoY Change	1.43%	302.88%	-10.31%
Operating Profit	-$9.878M	-$35.29M	-$35.29M
YoY Change	-2.38%	277.53%	-37.4%
Interest Expense	$513.0K	-$2.287M	$3.644M
YoY Change	15.02%	588.86%	190.13%
% of Operating Profit
Other Income/Expense, Net	$2.200M	-$2.396M	-$5.001M
YoY Change	-4.35%	-189.6%	-284.88%
Pretax Income	-$7.678M	-$39.97M	-$39.97M
YoY Change	-1.8%	470.61%	-25.52%
Income Tax		$318.0K	$318.0K
% Of Pretax Income
Net Earnings	-$7.678M	-$40.29M	-$40.29M
YoY Change	-1.8%	475.15%	-24.93%
Net Earnings / Revenue	-38390.0%	-1289.25%	-1289.25%
Basic Earnings Per Share	-$0.36		-$3.16
Diluted Earnings Per Share	-$0.36	-$3.16	-$3.16
COMMON SHARES
Basic Shares Outstanding	18.32M	15.17M	12.74M
Diluted Shares Outstanding	21.30M		12.74M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.55M	$32.98M	$32.98M
YoY Change	-14.16%	-13.95%	-13.95%
Cash & Equivalents	$23.55M	$32.98M	$32.98M
Short-Term Investments
Other Short-Term Assets	$2.426M	$2.230M	$2.230M
YoY Change	0.04%	25.14%	25.14%
Inventory		$0.00	$0.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$25.98M	$35.21M	$35.21M
YoY Change	-15.57%	-14.15%	-14.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.107M	$1.195M	$4.860M
YoY Change	-21.27%	-19.69%	-14.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$540.0K	$540.0K	$540.0K
YoY Change	815.25%	-72.45%	-72.45%
Total Long-Term Assets	$5.159M	$5.400M	$5.400M
YoY Change	-31.44%	-29.61%	-29.61%
TOTAL ASSETS
Total Short-Term Assets	$25.98M	$35.21M	$35.21M
Total Long-Term Assets	$5.159M	$5.400M	$5.400M
Total Assets	$31.14M	$40.61M	$40.61M
YoY Change	-18.69%	-16.59%	-16.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.327M	$2.303M	$2.303M
YoY Change	39.84%	-2.91%	-2.91%
Accrued Expenses	$4.870M	$5.241M	$4.737M
YoY Change	-23.26%	-17.48%	7.93%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.00K	$10.00K	$10.00K
YoY Change	11.11%	11.11%	11.11%
Total Short-Term Liabilities	$7.207M	$7.554M	$7.554M
YoY Change	-10.13%	-13.49%	-13.49%
LONG-TERM LIABILITIES
Long-Term Debt	$31.32M	$30.81M	$30.82M
YoY Change	132.39%	129.4%	129.17%
Other Long-Term Liabilities	$7.262M	$9.892M	$9.892M
YoY Change	9.57%	-9.26%	-9.26%
Total Long-Term Liabilities	$31.32M	$30.81M	$40.71M
YoY Change	132.39%	129.4%	67.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.207M	$7.554M	$7.554M
Total Long-Term Liabilities	$31.32M	$30.81M	$40.71M
Total Liabilities	$45.79M	$48.26M	$48.26M
YoY Change	62.74%	45.89%	45.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$595.7M	-$588.1M
YoY Change	7.22%	7.36%
Common Stock	$581.1M	$580.4M
YoY Change	2.71%	3.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$14.65M	-$7.657M	-$7.657M
YoY Change
Total Liabilities & Shareholders Equity	$31.14M	$40.61M	$40.61M
YoY Change	-18.69%	-16.59%	-16.59%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$7.678M	-$40.29M	-$40.29M
YoY Change	-1.8%	475.15%	-24.93%
Depreciation, Depletion And Amortization	$88.00K	$84.00K	$300.0K
YoY Change	7.32%	2.44%	-25.0%
Cash From Operating Activities	-$9.420M	-$5.985M	-$33.04M
YoY Change	-13.37%	-43.88%	-35.83%
INVESTING ACTIVITIES
Capital Expenditures		$21.00K	$41.00K
YoY Change			46.43%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities		-$21.00K	-$41.00K
YoY Change		-100.12%	-327.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$8.066M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.000K	4.031M	26.31M
YoY Change	50.0%	-49.33%	11.94%
NET CHANGE
Cash From Operating Activities	-9.420M	-5.985M	-33.04M
Cash From Investing Activities		-21.00K	-41.00K
Cash From Financing Activities	-3.000K	4.031M	26.31M
Net Change In Cash	-9.423M	-1.975M	-6.765M
YoY Change	-13.36%	-112.92%	-75.8%
FREE CASH FLOW
Cash From Operating Activities	-$9.420M	-$5.985M	-$33.04M
Capital Expenditures		$21.00K	$41.00K
Free Cash Flow		-$6.006M	-$33.08M
YoY Change		-43.68%	-35.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityCurrent http://www.trevenainc.com/20231231#LeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityCurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityCurrent http://www.trevenainc.com/20231231#LeaseLiabilityNoncurrent
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001429560
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023	dei	Entity Registrant Name EntityRegistrantName	TREVENA INC
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7744692
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17289104
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.04
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.04
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityCurrent http://www.trevenainc.com/20231231#LeaseLiabilityNoncurrent
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityCurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityNoncurrent
CY2022Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://www.trevenainc.com/20231231#LeaseLiabilityCurrent http://www.trevenainc.com/20231231#LeaseLiabilityNoncurrent
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-36193
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1469215
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	955 Chesterbrook Blvd.
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 110
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Chesterbrook
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19087
CY2023	dei	City Area Code CityAreaCode	610
CY2023	dei	Local Phone Number LocalPhoneNumber	354-8840
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023	dei	Trading Symbol TradingSymbol	TRVN
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	12000000.0
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18321010
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32975000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38320000
CY2022Q4	us-gaap	Inventory Net InventoryNet	906000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2230000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1782000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	35205000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	41008000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	540000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1960000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1195000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1488000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3665000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4224000
CY2023Q4	us-gaap	Assets Assets	40605000
CY2022Q4	us-gaap	Assets Assets	48680000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2303000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2372000
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	4239000
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5461000
CY2023Q4	trvn	Lease Liability Current LeaseLiabilityCurrent	1012000
CY2022Q4	trvn	Lease Liability Current LeaseLiabilityCurrent	899000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7554000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8732000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	30809000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13430000
CY2023Q4	trvn	Lease Liability Noncurrent LeaseLiabilityNoncurrent	4424000
CY2022Q4	trvn	Lease Liability Noncurrent LeaseLiabilityNoncurrent	5436000
CY2023Q4	trvn	Preferred Stock Warrant Liability Non Current PreferredStockWarrantLiabilityNonCurrent	5475000
CY2022Q4	trvn	Preferred Stock Warrant Liability Non Current PreferredStockWarrantLiabilityNonCurrent	5483000
CY2023Q4	us-gaap	Liabilities Liabilities	48262000
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-40289000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53669000
CY2022Q4	us-gaap	Liabilities Liabilities	33081000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17289104
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7744692
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	17000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	580387000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	563362000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-588061000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-547772000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-7657000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15599000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40605000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48680000
CY2023	trvn	Revenue From Contract With Customer Including Assessed Tax Net Of Returns Reserve RevenueFromContractWithCustomerIncludingAssessedTaxNetOfReturnsReserve	3125000
CY2022	trvn	Revenue From Contract With Customer Including Assessed Tax Net Of Returns Reserve RevenueFromContractWithCustomerIncludingAssessedTaxNetOfReturnsReserve	-418000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1670000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	3018000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20410000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34728000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16333000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18211000
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	38413000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	55957000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-35288000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-56375000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2126000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11180000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4522000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7681000
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	1398000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	451000
CY2023	us-gaap	Interest Expense InterestExpense	3644000
CY2022	us-gaap	Interest Expense InterestExpense	1256000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-41000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	11000
CY2023	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	318000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5001000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2705000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-40289000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-53670000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.16
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.16
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.59
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.59
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12735010
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12735010
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7072362
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7072362
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	64629000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3676000
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	603000
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-37000
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	397000
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53670000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15599000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2930000
CY2023	trvn	Stock Issued During Period Value Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants	2003000
CY2023	trvn	Stock Issued During Period Value Common Stock Warrants Net Exercised StockIssuedDuringPeriodValueCommonStockWarrantsNetExercised	3875000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	161000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8067000
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-2000
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-40289000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-7657000
CY2023	us-gaap	Profit Loss ProfitLoss	-40289000
CY2022	us-gaap	Profit Loss ProfitLoss	-53670000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	334000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	382000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2930000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3676000
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	1634000
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	128000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	896000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	2070000
CY2023	trvn	Value Of Warrants Issued For Exercise Inducement ValueOfWarrantsIssuedForExerciseInducement	4674000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2126000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11180000
CY2023	trvn	Returns Reserve Adjustment ReturnsReserveAdjustment	107000
CY2022	trvn	Returns Reserve Adjustment ReturnsReserveAdjustment	383000
CY2022	trvn	Fair Value Of Warrants In Excess Of Proceeds FairValueOfWarrantsInExcessOfProceeds	7147000
CY2022	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	46000
CY2023	trvn	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-559000
CY2022	trvn	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-482000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-522000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1209000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	624000
CY2023	trvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-887000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-51477000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	33000000
CY2022	trvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-758000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1399000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-676000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33035000
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	32954000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	18000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8066000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	37000
CY2023	trvn	Proceeds From Issuance Of Common Stock Warrants And Prefunded Warrants ProceedsFromIssuanceOfCommonStockWarrantsAndPrefundedWarrants	1426000
CY2022	trvn	Proceeds From Issuance Of Common Stock Warrants And Prefunded Warrants ProceedsFromIssuanceOfCommonStockWarrantsAndPrefundedWarrants	7997000
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2056000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8000
CY2023	trvn	Proceeds From Prefunded Warrants Exercised ProceedsFromPrefundedWarrantsExercised	2000
CY2022	trvn	Proceeds From Issuance Of Long Term Debt And Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfLongTermDebtAndProceedsFromIssuanceOfWarrants	1647000
CY2023	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	14775000
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	13906000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	26311000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23505000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6765000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-27954000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40280000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68234000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33515000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40280000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	801000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	604000
CY2022	trvn	Allocation Of Loan Payable Proceeds To Common Stock Warrants AllocationOfLoanPayableProceedsToCommonStockWarrants	603000
CY2022	trvn	Preferred Stock Proceeds Allocated To Warrant Liability PreferredStockProceedsAllocatedToWarrantLiability	603000
CY2023	trvn	Reclassification Of Warrant Liability Upon Exercise Of Prefunded Warrants ReclassificationOfWarrantLiabilityUponExerciseOfPrefundedWarrants	2001000
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	397000
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-588100000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-40300000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53700000
CY2022Q2	trvn	Number Of Wholly Owned Subsidiaries NumberOfWhollyOwnedSubsidiaries	3
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management used significant estimates in the following areas, among others: stock-based compensation expense, the determination of the fair value of stock-based awards, the fair value of common stock warrants, the accounting for research and development costs, accrued expenses, the recoverability of the Company’s net deferred tax assets and related valuation allowance, and the amortization of the debt expenses. The financial data and other information disclosed in these notes are not necessarily indicative of the results to be expected for any future year or period. The Company bases its estimates on historical experience and also on assumptions that it believes are reasonable, however, actual results could significantly differ from those results.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents, and restricted cash. The Company’s investment policy includes guidelines on the quality of the institutions and financial instruments and defines allowable investments that the Company believes minimizes the exposure to concentration of credit risk. The Company has no off-balance sheet concentrations of credit risk such as foreign currency exchange contracts, option contracts or other hedging arrangements.</p>
CY2023	trvn	Number Of Stock Based Compensation Plans NumberOfStockBasedCompensationPlans	3
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2762000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1195000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1488000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	300000
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	3159000
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	33515000
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	5475000
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	9651000
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	40280000
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	5483000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	896000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3111000
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	896000
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2205000
CY2022Q4	us-gaap	Inventory Net InventoryNet	906000
CY2023	trvn	Increase Decrease In Inventory Valuation Adjustment IncreaseDecreaseInInventoryValuationAdjustment	900000
CY2022	trvn	Increase Decrease In Inventory Valuation Adjustment IncreaseDecreaseInInventoryValuationAdjustment	2100000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3794000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4250000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2599000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	400000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2093000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1965000
CY2023Q4	trvn	Accrued Commercial Expenses Current AccruedCommercialExpensesCurrent	43000
CY2022Q4	trvn	Accrued Commercial Expenses Current AccruedCommercialExpensesCurrent	93000
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	423000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	381000
CY2023Q4	trvn	Accrued Clinical Trial Fees Current AccruedClinicalTrialFeesCurrent	38000
CY2022Q4	trvn	Accrued Clinical Trial Fees Current AccruedClinicalTrialFeesCurrent	1421000
CY2023Q4	trvn	Accrued Development Expenses Current AccruedDevelopmentExpensesCurrent	398000
CY2022Q4	trvn	Accrued Development Expenses Current AccruedDevelopmentExpensesCurrent	201000
CY2022Q4	trvn	Accrued Credit Balances To Customers AccruedCreditBalancesToCustomers	67000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	522000
CY2023Q4	trvn	Other Accrued Expenses And Other Current Liabilities OtherAccruedExpensesAndOtherCurrentLiabilities	1244000
CY2022Q4	trvn	Other Accrued Expenses And Other Current Liabilities OtherAccruedExpensesAndOtherCurrentLiabilities	811000
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	4239000
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5461000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	32232000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1423000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	30809000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q3	trvn	Proceeds From Issuance Of Convertible Preferred Stock Gross ProceedsFromIssuanceOfConvertiblePreferredStockGross	2000000
CY2022Q4	trvn	Common Stock Warrant Liability Noncurrent CommonStockWarrantLiabilityNoncurrent	5400000
CY2023Q4	trvn	Common Stock Warrant Liability Noncurrent CommonStockWarrantLiabilityNoncurrent	5500000
CY2023Q4	trvn	Increase Decrease In Common Stock Warrant Liability Noncurrent IncreaseDecreaseInCommonStockWarrantLiabilityNoncurrent	100000
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	11639586
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2930000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3676000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	13645658
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3665000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4224000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1002000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	890000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4417000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5419000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5419000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6309000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	10000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	7000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	17000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	17000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	26000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1458000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1308000
CY2023	us-gaap	Sublease Income SubleaseIncome	1392000
CY2022	us-gaap	Sublease Income SubleaseIncome	1330000
CY2023	trvn	Operating Lease Income Expense Net OperatingLeaseIncomeExpenseNet	66000
CY2022	trvn	Operating Lease Income Expense Net OperatingLeaseIncomeExpenseNet	-22000
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	10000
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	7000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000
CY2023	trvn	Finance Lease Cost FinanceLeaseCost	12000
CY2022	trvn	Finance Lease Cost FinanceLeaseCost	8000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	452000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	295000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8000
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1450000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	11000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1474000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	7000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1499000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1523000
CY2023Q4	trvn	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	640000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6586000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	18000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1167000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	1000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5419000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	17000
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	1158000
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	1178000
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	1198000
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	1166000
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	254000
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	4954000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065
CY2022Q4	trvn	Accounts Receivable Allowance For Credit Loss Sales Discounts AccountsReceivableAllowanceForCreditLossSalesDiscounts	1000
CY2022Q4	trvn	Accounts Receivable Allowance For Credit Loss Chargebacks AccountsReceivableAllowanceForCreditLossChargebacks	30000
CY2022Q4	trvn	Accounts Receivable Allowance For Credit Loss Fee For Service AccountsReceivableAllowanceForCreditLossFeeForService	36000
CY2023	trvn	Accounts Receivable Credit Loss Sales Discounts Provision Related To Current Period Sales AccountsReceivableCreditLossSalesDiscountsProvisionRelatedToCurrentPeriodSales	1000
CY2023	trvn	Accounts Receivable Credit Loss Chargebacks Provision Related To Current Period Sales AccountsReceivableCreditLossChargebacksProvisionRelatedToCurrentPeriodSales	5000
CY2023	trvn	Accounts Receivable Credit Loss Fee For Service Provision Related To Current Period Sales AccountsReceivableCreditLossFeeForServiceProvisionRelatedToCurrentPeriodSales	5000
CY2023	trvn	Accounts Receivable Credit Loss Sales Discounts Credit Or Payments Made During Period AccountsReceivableCreditLossSalesDiscountsCreditOrPaymentsMadeDuringPeriod	1000
CY2023	trvn	Accounts Receivable Credit Loss Chargebacks Credit Or Payments Made During Period AccountsReceivableCreditLossChargebacksCreditOrPaymentsMadeDuringPeriod	9000
CY2023	trvn	Accounts Receivable Credit Loss Fee For Service Credit Or Payments Made During Period AccountsReceivableCreditLossFeeForServiceCreditOrPaymentsMadeDuringPeriod	16000
CY2023	trvn	Accounts Receivable Credit Loss Sales Discounts Expense Reversal AccountsReceivableCreditLossSalesDiscountsExpenseReversal	1000
CY2023	trvn	Accounts Receivable Credit Loss Chargebacks Expense Reversal AccountsReceivableCreditLossChargebacksExpenseReversal	-7000
CY2023	trvn	Accounts Receivable Credit Loss Fee For Service Expense Reversal AccountsReceivableCreditLossFeeForServiceExpenseReversal	-16000
CY2023Q4	trvn	Accounts Receivable Allowance For Credit Loss Sales Discounts AccountsReceivableAllowanceForCreditLossSalesDiscounts	2000
CY2023Q4	trvn	Accounts Receivable Allowance For Credit Loss Chargebacks AccountsReceivableAllowanceForCreditLossChargebacks	19000
CY2023Q4	trvn	Accounts Receivable Allowance For Credit Loss Fee For Service AccountsReceivableAllowanceForCreditLossFeeForService	9000
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	30000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-40289000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53670000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12735010
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12735010
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7072362
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7072362
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.16
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.16
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.59
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.59
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10865752
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3858538
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	318000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	318000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	318000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-9200000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7500000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	55817000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	46490000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	16839000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	16309000
CY2023Q4	trvn	Deferred Tax Assets Research And Development Expenses Capitalized For Tax Purposes DeferredTaxAssetsResearchAndDevelopmentExpensesCapitalizedForTaxPurposes	80046000
CY2022Q4	trvn	Deferred Tax Assets Research And Development Expenses Capitalized For Tax Purposes DeferredTaxAssetsResearchAndDevelopmentExpensesCapitalizedForTaxPurposes	80648000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2200000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2257000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	437000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	520000
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	369000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	365000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1338000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1192000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	157046000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	147781000
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	506000
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	436000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	506000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	436000
CY2023Q4	trvn	Deferred Tax Assets Liabilities Net Before Valuation Allowance DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance	156540000
CY2022Q4	trvn	Deferred Tax Assets Liabilities Net Before Valuation Allowance DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance	147345000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	156540000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	147345000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	trvn	Effective Income Tax Rate Reconciliation Withholding Tax Percent EffectiveIncomeTaxRateReconciliationWithholdingTaxPercent	-0.008
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.014
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.013
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.032
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.048
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.013
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.015
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.377
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.012
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.032
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.017
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.230
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.140
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.008
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023	trvn	Research And Development Expense Capitalized ResearchAndDevelopmentExpenseCapitalized	15700000
CY2023	trvn	Effective Income Tax Rate Reconciliation At State Statutory Income Tax Rate Percent EffectiveIncomeTaxRateReconciliationAtStateStatutoryIncomeTaxRatePercent	0.0999
CY2023	trvn	Deferred State And Local Income Tax Expense From Change In Tax Rates Benefit DeferredStateAndLocalIncomeTaxExpenseFromChangeInTaxRatesBenefit	25700000
CY2023	trvn	Defined Contribution Plan Employer Matching Contribution Percent Of Match For First Eligible Contributions DefinedContributionPlanEmployerMatchingContributionPercentOfMatchForFirstEligibleContributions	1
CY2023	trvn	Defined Contribution Plan Employer Match Employee Contribution Level One DefinedContributionPlanEmployerMatchEmployeeContributionLevelOne	0.03
CY2023	trvn	Defined Contribution Plan Employer Matching Contribution Percent Of Match For Second Eligible Contributions DefinedContributionPlanEmployerMatchingContributionPercentOfMatchForSecondEligibleContributions	0.50
CY2023	trvn	Defined Contribution Plan Employer Match Employee Contribution Level Two DefinedContributionPlanEmployerMatchEmployeeContributionLevelTwo	0.02
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	300000
CY2023	dei	Auditor Firm AuditorFirmId	42

Files In Submission

Name	View Source	Status
0001558370-24-004445-index-headers.html	Edgar Link	pending
0001558370-24-004445-index.html	Edgar Link	pending
0001558370-24-004445.txt	Edgar Link	pending
0001558370-24-004445-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trvn-20231231.xsd	Edgar Link	pending
trvn-20231231x10k.htm	Edgar Link	pending
trvn-20231231x10k003.jpg	Edgar Link	pending
trvn-20231231xex10d20.htm	Edgar Link	pending
trvn-20231231xex10d21.htm	Edgar Link	pending
trvn-20231231xex10d23.htm	Edgar Link	pending
trvn-20231231xex10d27.htm	Edgar Link	pending
trvn-20231231xex23d1.htm	Edgar Link	pending
trvn-20231231xex31d1.htm	Edgar Link	pending
trvn-20231231xex31d2.htm	Edgar Link	pending
trvn-20231231xex32d1.htm	Edgar Link	pending
trvn-20231231xex32d2.htm	Edgar Link	pending
trvn-20231231xex97.htm	Edgar Link	pending
trvn-20231231_def.xml	Edgar Link	unprocessable
trvn-20231231_lab.xml	Edgar Link	unprocessable
trvn-20231231_pre.xml	Edgar Link	unprocessable
trvn-20231231x10k_htm.xml	Edgar Link	completed
trvn-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRVN
TREVENA INC Stock $trvn

2024 Q1 Form 10-K Financial Statement

#000155837024004445 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRVN TREVENA INC Stock $trvn

2024 Q1 Form 10-K Financial Statement

#000155837024004445 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRVN
TREVENA INC Stock $trvn